The Canadian Nuclear Isotope Council (CNIC) has announced Canada’s first official contribution to the IAEA Rays of Hope initiative — the International Atomic Energy Agency program aimed at expanding access to cancer care in low- and middle-income countries. This is not a financial pledge, but a concrete knowledge transfer: expertise, laboratories, and facilities made available to Latin America.
From November 8 to 14, 2026, twenty-six professionals from Argentina, Brazil, Chile, and Mexico will take part in a training program hosted at Bruce Power and the laboratories of McMaster University in Ontario. The curriculum covers isotope and radiopharmaceutical production, quality control, and regulatory compliance, blending classroom instruction with hands-on work at operational facilities. It is a direct transfer of know-how, built around Canada’s already-functioning isotope production chain.
IAEA Director General Rafael Mariano Grossi described the CNIC’s initiative as “Atoms for Peace in action,” highlighting how the collaboration between private industry, academia, and institutions lies at the heart of Rays of Hope. The announcement follows a meeting held in Vienna in February 2026 between CNIC leadership, Grossi, and Canada’s Ambassador to International Organizations, Alison Grant, where the terms of the contribution were discussed. The partnership has been in the making for some time: back in March 2025, CNIC and the IAEA had already signed operational agreements to establish the framework for cooperation.
The context driving this initiative is well documented. Low- and middle-income countries account for more than 70% of global cancer deaths, yet receive only 5% of total sector spending. Rays of Hope aims to bridge this gap by distributing radiotherapy equipment, medical training, and technical support. Since 2022, more than twenty countries have contributed to the initiative, committing over $105 million and reaching more than thirty nations. Canada’s approach is distinct: in-kind contributions rooted in its long-standing tradition of medical radioisotope production.
The CNIC is an independent, not-for-profit organization representing Canada’s isotope industry — historically one of the most advanced in the world. Its stated vision is to double Canada’s isotope production by 2030, combining domestic growth with an international outlook. This first contribution to Rays of Hope is not a one-off gesture, but the practical application of that strategy: leveraging Canadian infrastructure to train regulators and technicians in the countries that need them most, building lasting local capacity.
If the model proves effective, it could become a replicable template. The training hosted at Bruce Power and McMaster requires no direct financial outlay, but draws on what Canada already has: operating reactors, specialized universities, and a proven medical isotope supply chain. It is a way of exporting nuclear expertise that can precede — and in some cases replace — heavy infrastructure investment. For the Latin American countries involved, the value is immediate: returning home with trained personnel, acquired protocols, and a professional network in the country that produces a significant share of the world’s medical isotopes.
